Leading brokers name 3 ASX shares to buy today

The Sigma Healthcare Ltd (ASX:SIG) share price is one of three which could be given a lift this week after it was labelled as a buy by brokers. Should you invest in all three?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Yesterday I took a quick look at a number of unfortunate shares which brokers had just slapped sell ratings on.

Today I thought I would look at shares which have found favour with brokers and have been given buy ratings. Here they are:

McPherson's Ltd (ASX: MCP)

A research note out of Shaw and Partners yesterday revealed that its analysts have slapped a buy rating and $1.85 price target on the household and beauty products company's shares. The broker appears to believe that McPherson's is trading at a significant discount to its peers and could be rerated in the near future. While 10x trailing earnings is certainly cheap, the company does look likely to deliver a third successive year of sales declines in FY 2017. I'd prefer to invest in companies which are exhibiting strong sales growth.

Sigma Healthcare Ltd (ASX: SIG)

Credit Suisse has upgraded the pharmacy operator and supplier to an outperform rating with a 90 cents price target. According to the note the broker believes that the market has been overly negative on its legal action against Chemist Warehouse. Although it acknowledges that losing a contract with its major customer would be difficult, it sees opportunities for Sigma to reinvest freed up working capital in earnings accretive acquisitions. Although I agree with this view, I'm not convinced that Sigma's shares have found their bottom yet. This could make it one to avoid.

Wesfarmers Ltd (ASX: WES)

According to a note out of Macquarie, its analysts have reiterated their outperform rating and $45.00 price target on Wesfarmers' shares following a series of executive appointments. The broker appears confident that the new management team will ensure that the next few years are successful, delivering earnings growth and improved returns. At the current share price I think Wesfarmers is a good, but not great option for income investors.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »